Literature DB >> 32557713

Differences in race and other state-level characteristics and associations with mortality from COVID-19 infection.

Shiv T Sehra1,2, Shelby Fundin3, Criswell Lavery4,5, Joshua F Baker4,5,6.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32557713      PMCID: PMC7301019          DOI: 10.1002/jmv.26095

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   20.693


× No keyword cloud information.
As of 1st May 2020, New York state has experienced the greatest mortality from coronavirus disease‐2019 (COVID‐19) in the United States. Mortality in New York, weighted for racial distribution is higher in the African American population. We investigated the relationship between race and mortality across the United States. Daily new COVID‐19 cases and deaths from 22 January 2020 to 18 April 2020 were obtained from the COVID‐19 Global Cases dashboard hosted by the Center for Systems Science and Engineering at Johns Hopkins University (https://github.com/CSSEGISandData/COVID-19). State population was collected from the 2019‐US Census Bureau estimates. Race, age, and gender were collected from 2018‐American Community Survey, US Census Bureau. Obesity rates were obtained from the Centers for Disease Control and Prevention's Behavioral Risk Factor Surveillance System. , , , , , Primary exposure was the proportion of people in each state that self‐categorized as African American. Daily deaths were modeled using Poisson regression incorporating generalized estimating equations (robust estimators, exchangeable correlation matrices). In primary analyses, we modeled the rate of daily deaths 14‐days from the date after cases reached more than 1/million in each state. Cubic splines characterized time in two discreet periods, before and after the institution of stay‐at‐home orders in each state. State characteristics assessed included population density, people older than 65 years and less than 18 years, obesity rates, insurance data, state gross domestic product (GDP), hospital beds/ventilators per capita, median family income, and high‐school graduation rates. The null hypothesis was that there was no association between this state‐level exposure and mortality from COVID‐19. Sensitivity analyses included varying the time between new cases and deaths (10 and 18 days) and using single outcome of the number of deaths at 29 days from the first day that the case rate reached more than 1/million for each state. States where a higher proportion of people who reported African American race or other races had higher death rates, despite accounting for state level differences in cases rates, age, obesity, population density, implementation of stay‐at‐home orders, uninsured rates, state GDP, and other health care resources (Table 1). Based on these models, the rates of death were substantially greater over time among a hypothetical state with 30% African American residents, compared with a hypothetical state with 10% African American residents (Figure 1). A greater proportion of children and a higher population density were each associated with lower death rates, while the number of current cases (per million) was associated higher death rates 14‐days later. States with a higher proportion of private‐insurance and Medicare‐insured residents also showed higher mortality‐rates (incident rate ratio for Medicare [per 1%]: 1.61 [1.06‐2.46] P = .03). Mortality‐rates were not higher in states with greater rates of obesity or in states with a higher proportion of older residents. Sensitivity analyses were highly similar to the primary analysis (not shown).
Table 1

Multivariable Poisson regression models evaluating associations between state‐level factors and case rates 14 days from current day

Mortality rate from COVID‐19 a Mortality rate from COVID‐19 b
IRR (95% CI) P IRR (95% CI) P
% African American (per 1% of population)1.07 (1.02‐1.12).0031.07 (1.02‐1.12).006
% Other race (per 1% of population)1.12 (1.03‐1.23).0081.27 (1.13‐1.42)<.001
Case rate (per 100 000)1.03 (1.01‐1.04).0011.02 (1.01‐1.04).007
Date (per d) (before distancing)1.09 (1.08‐1.11)<.0011.09 (1.07‐1.11)<.001
Date (per d) (after distancing)1.00 (1.00‐1.01).0021.00 (1.00‐1.00).002
Population density (per 1000/mile2)0.73 (0.61‐0.87)<.0010.79 (0.65‐0.97).02
% >65 y (per 1% of population)0.97 (0.75‐1.25).821.08 (0.84‐1.39).57
% <18 y (per 1% of population)0.66 (0.51‐0.86).0020.67 (0.54‐0.84)<.001
% Obese (per 1% of population)0.91 (0.79‐1.03).151.00 (0.87‐1.16).96
% Private insurance (per 1%)1.12 (1.04‐1.21).003

Note: Other factors evaluated and not included in final models: high‐school graduation rates, % Asian, % Pacific Islander, % American Indian, state GDP, median family income, ventilators per capita, hospital beds per capita, % uninsured, and % with Medicare.

Abbreviations: CI, confidence interval; COVID‐19, coronavirus disease‐2019; GDP, gross domestic product; IRR, incident rate ratio.

Model 1.

Model 2.

Figure 1

Predicted Mortality (per million population) in Hypothetical US States

Multivariable Poisson regression models evaluating associations between state‐level factors and case rates 14 days from current day Note: Other factors evaluated and not included in final models: high‐school graduation rates, % Asian, % Pacific Islander, % American Indian, state GDP, median family income, ventilators per capita, hospital beds per capita, % uninsured, and % with Medicare. Abbreviations: CI, confidence interval; COVID‐19, coronavirus disease‐2019; GDP, gross domestic product; IRR, incident rate ratio. Model 1. Model 2. Predicted Mortality (per million population) in Hypothetical US States The primary observation of our study supports prior observations of higher death rates among African American patients. , While higher death rates among African American patients speaks to an important public health concern, these data are not able to fully consider potential confounding factors on a granular level. Whether the underlying factors that might account for the difference in death rates may be due to genetic, socioeconomic, or related to health care access, remains unclear. Lower death rates were observed in states with more children and states with a higher population density. Availability of health care resources, urban distribution of residents, and other demographic differences that are difficult to clarify in these data, may explain the lower mortality in high population density areas. Rates of obesity and older age were not associated with mortality, conflicting with other evidence to support these populations being at greater risk. , It is likely that these exposures do not sufficiently vary by state or may not adequately capture the risk related to these exposures. Study at a more granular level is needed to further characterize these exposures.

CONFLICT OF INTERESTS

All the authors declare that there are no conflict of interests.
  2 in total

1.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

Authors:  Safiya Richardson; Jamie S Hirsch; Mangala Narasimhan; James M Crawford; Thomas McGinn; Karina W Davidson; Douglas P Barnaby; Lance B Becker; John D Chelico; Stuart L Cohen; Jennifer Cookingham; Kevin Coppa; Michael A Diefenbach; Andrew J Dominello; Joan Duer-Hefele; Louise Falzon; Jordan Gitlin; Negin Hajizadeh; Tiffany G Harvin; David A Hirschwerk; Eun Ji Kim; Zachary M Kozel; Lyndonna M Marrast; Jazmin N Mogavero; Gabrielle A Osorio; Michael Qiu; Theodoros P Zanos
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

2.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

  2 in total
  6 in total

1.  The risks and opportunities of the COVID-19 crisis for building longitudinal evidence on today's early childhood education programs.

Authors:  Christina Weiland; Pamela Morris
Journal:  Child Dev Perspect       Date:  2022-02-26

2.  Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland.

Authors:  James C Doidge; Doug W Gould; Paloma Ferrando-Vivas; Paul R Mouncey; Karen Thomas; Manu Shankar-Hari; David A Harrison; Kathryn M Rowan
Journal:  Am J Respir Crit Care Med       Date:  2021-03-01       Impact factor: 21.405

3.  Changes in COVID-19-Associated Deaths During a Year Among Blacks and Hispanics Compared to Whites in the State of Connecticut.

Authors:  Cato T Laurencin; Z Helen Wu; James J Grady; Rong Wu; Joanne M Walker
Journal:  J Racial Ethn Health Disparities       Date:  2021-09-28

4.  Examining longitudinal disparities in COVID-19 prevalence in the U.S.: a county level growth rate perspective.

Authors:  Amin Kiaghadi; Omolola E Adepoju; Hanadi S Rifai; Winston Liaw; Lechauncy D Woodard
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

5.  Complex systems models for causal inference in social epidemiology.

Authors:  Hiba N Kouser; Ruby Barnard-Mayers; Eleanor Murray
Journal:  J Epidemiol Community Health       Date:  2020-11-10       Impact factor: 3.710

6.  Historical Redlining and Resident Exposure to COVID-19: A Study of New York City.

Authors:  Min Li; Faxi Yuan
Journal:  Race Soc Probl       Date:  2021-06-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.